08:00 , Jan 29, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cardiovascular disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Cerebral cavernous malformation (CCM); vascular dysplasia Cerebral cavernous malformation 2 (CCM2); ras homolog gene family, member A (RHOA); HMG-CoA reductase...